AzTrials
AzTrials

Harmful DrinkingNCT00443183

Emergency Physician Brief Interventions for Alcohol

A study testing Brief Negotiation Interview (BNI) and Discharge Instructions in people with Harmful Drinking and Hazardous Drinking, run by Yale University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients with hazardous and harmful alcohol consumption are at increased risk for adverse health consequences and have frequent visits to the Emergency Department(ED). Despite research that has demonstrated the prevalence of alcohol problems in ED patients, there are limited data on the effectiveness of brief… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Harmful Drinking, Hazardous Drinking
What is being tested?
Brief Negotiation Interview (BNI) and Discharge Instructions
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
500 participants
Where
1 siteUnited States
Study dates
May 2002to Nov 2004
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients, 18 years or older who present to the adult ED at Yale-New Haven Hospital will be screened for the NIAAA criteria for at risk drinking( ) namely:
  • Men: > 14 drinks per week or > 4 drinks per occasion
  • Women \&: > 7 drinks per week or (all >65) > 3 drinks per occasion
  • or will be considered to screen positive for harmful drinking, if they exhibit any current injury or medical condition occurring in the setting of acute alcohol ingestion as determined by a) self-report; b)serum or breathalyzer test with a blood alcohol concentration (BAC) > 0.02mg%;( , , ) or c) a history of any injury or medical condition involving the use of alcohol within the past year.

Who cannot join

  • Patients will be excluded for the following:
  • Non-English speaking;
  • Pregnancy;
  • Alcohol dependence;
  • Current enrollment in substance abuse treatment program;
  • Current cocaine or illicit opiate use;
Show all 12Show fewer
  • Current ED visit for acute psychiatric complaint;
  • History of neuroleptic prescription;
  • Hospitalization for psychiatric problem in the past year;
  • Condition that precludes interview i.e., life threatening injury/illness;
  • In police custody; and
  • Inability to provide 2 contact numbers for follow-up.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Yale University

    New Haven, Connecticut, 06519

Other trials in United States

About this study

Patients with hazardous and harmful alcohol consumption are at increased risk for adverse health consequences and have frequent visits to the Emergency Department(ED). Despite research that has demonstrated the prevalence of alcohol problems in ED patients, there are limited data on the effectiveness of brief intervention (BI) strategies for patients in this setting. The purpose of the current study is to evaluate the effectiveness of a brief intervention, termed Brief Negotiation Interview (BNI), provided by emergency practitioners (EPs-emergency physicians and physician assistants), in reducing alcohol consumption in ED patients with hazardous and harmful drinking. In a controlled randomized clinical trial of 500 patients with hazardous and harmful drinking, BNI will be compared to scripted discharge instructions (DI). Three hypotheses will be tested: BNI is superior to DI in: 1) reducing alcohol consumption; 2) reducing the number of binge drinking episodes; and 3) increasing utilization of primary care or alcohol-related services. Alcohol consumption and utilization of primary care or alcohol-related services will be measured by self-report at 1,6 and 12 months. An additional benefit to changing patterns of consumption and utilization of health services may be decreased ED visits and alcohol-related hospitalizations. These will be assessed utilizing a statewide database. In order to facilitate real-world application of BNI in the ED, the project will result in a BNI manual for EPs and an adherence and competence scale. Unique features of the current project as compared to earlier studies include: 1)use of a credible control condition; 2) enrollment of a heterogeneous population; 3)use of a manual-guided intervention by existing ED staff; 4)systematic assessment of adherence and competence to ensure quality administration and discriminability of interventions; 5)monitoring of use of ancillary treatments; and 6)monitoring of repeat ED visits and alcohol-related hospitalizations.

Being tested
Brief Negotiation Interview (BNI), Discharge Instructions

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief Negotiation Interview (BNI)Behavioural

    The Brief Negotiation Interview is a manual guided intervention using techniques based on motivational interviewing, brief advice, and behavioral contracting and is designed to be delivered in less than 10 minutes.

  • Discharge InstructionsBehavioural

    Used as a placebo comparator, scripted discharge instructions are to be read by emergency practitioner and designed to be less than 1 minute in length.

Study groups in NCT00443183
Study groupRoleWhat they receive
Brief Negotiation InterviewExperimentalThe Brief Negotiation Interview is a manual guided intervention using techniques based on motivational interviewing, brief advice, and behavioral contracting and is designed to be delivered in less than 10 minutes.
Receives: Behavioral: Brief Negotiation Interview (BNI)
Discharge InstructionsPlacebo comparatorScripted discharge instructions to be read by emergency practitioner and designed to be less than 1 minute in length.
Receives: Behavioral: Discharge Instructions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Drinks Consumed Daily for the Past 30 Days

    Measured: Baseline (Before Intervention)

  2. Number of Drinks Consumed Per Week

    Measured: After 6 Months

  3. Number of Drinks Consumed Per Week

    Measured: After 12 Months

  4. Number of Binge Episodes in the Past 30 Days

    Greater than 4 drinks for women and greater than 5 drinks for men

    Measured: After 6 Months

  5. Number of Binge Episodes in the Past 30 Days

    Greater than 4 drinks for women and greater than 5 drinks for men

    Measured: After 12 Months

Secondary outcomes (4)
  1. Contemplation Ladder Scores

    A brief measure of motivation or readiness to change, allowing patients to indicate their motivation to change their drinking from 1 to 10, in which 2 is least motivated and 10 is most motivated.

    Measured: After 6 Months

  2. Contemplation Ladder Scores

    A brief measure of motivation or readiness to change, allowing patients to indicate their motivation to change their drinking from 1 to 10, in which 2 is least motivated and 10 is most motivated.

    Measured: After 12 Months

  3. Short Form Health Survey

    Assess health status in 2 domains, physical and mental, including summary measures and overall general health perceptions.

    Measured: After 6 Months

  4. Short Form Health Survey

    Assess health status in 2 domains, physical and mental, including summary measures and overall general health perceptions.

    Measured: After 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2007 (estimated)
  2. Study startMay 2002
  3. Primary completionNov 2004
  4. Study completionNov 2004

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
500 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00443183
Sponsor's protocol ID
9906010726
Other IDs
5R01AA012417-03
Status last verified
Aug 2016
First submitted
1 Mar 2007
Last updated
30 Mar 2020
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Brief Negotiation Interview (BNI) and Discharge Instructions in people with Harmful Drinking and Hazardous Drinking, run by Yale University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Drinks Consumed Daily for the Past 30 Days (time frame: Baseline (Before Intervention)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2020; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in